Influenza cases rise in Tahiti as health authorities urge vaccination
Influenza continues to circulate in Tahiti, with health authorities reporting cases, hospitalizations and deaths since the beginning of October.
HealthTrending
Tahiti's influenza epidemic continues, with health authorities reporting confirmed cases, hospitalizations and deaths since early October, while chickenpox cases also increase.
By Hermes Vector

Influenza continues to circulate in Tahiti, with health authorities reporting cases, hospitalizations and deaths since the beginning of October.
Radio1 Tahiti reports that 155 confirmed influenza cases have been recorded since the beginning of October, with 55 hospitalizations and three deaths. The outlet notes that the figure counts confirmed cases and does not include people who may not seek medical attention.
TNTV News, citing the latest health surveillance bulletin published on Monday, 16 November, reports 283 confirmed cases since surveillance began on 5 October, with 93 hospitalizations and three deaths. For the week of 2 to 8 November, the bulletin recorded 111 laboratory-confirmed cases, 38 hospitalizations and four intensive care admissions, with no deaths reported that week.
The influenza vaccination campaign began on 26 October and will continue until 30 April 2027, according to Radio1 Tahiti. Vaccination is free for eligible groups at all Direction de la santé care structures and at contracted pharmacies in Tahiti, Moorea and the Îles Sous-le-Vent.
Eligible groups include people over 60, pregnant women, people with chronic or serious illnesses, people with severe obesity, close contacts of infants under six months, residents of long-term care facilities, health professionals, and air and maritime navigation personnel.
TNTV News reports that chickenpox cases are also increasing in Tahiti since the beginning of October, though the bulletin does not specify the number of people affected. One case of leptospirosis was reported in Raiatea, and two cases of Salmonella infection and one case of Campylobacter infection were reported for the week of 2 November.
Health authorities describe influenza as a serious respiratory infection that can lead to severe complications such as pneumonia, and they are urging barrier gestures and vaccination for vulnerable populations.
Sources
This article was drafted with AI assistance and checked against the sources above. Company claims are reported as claims. Cover image is AI-generated.
The day's checked news, by email
One short email a day with the top stories. Free, and you can unsubscribe in one click.
Or follow for the latest news:
No comments yet. Start the discussion.
Researchers from Beihang University in Beijing report an electronic comb called Detangle achieved nearly 100 percent hair regrowth in mice with androgenetic alopecia, outperforming minoxidil in the study. The device has not been tested on humans.
CG Oncology says cretostimogene grenadenorepvec reduced recurrence risk by 68% in the 367-patient PIVOT-006 trial, with two FDA filings planned for 2027.